Anthony Lembo,Harvey Schneier,Steven J. Shiff,Allen W. Mangel,James E. MacDougall,Xinwei D. Jia,James Shao,Bernard J. Lavins,Mark G. Currie,Donald A. Fitch,Brenda I. Jeglinski,Paul Eng,Susan M. Fox,Jeffrey M. Johnston
Linaclotide is a minimally absorbed peptide agonist of the guanylate cyclase C receptor. In two trials, we aimed to determine the efficacy and safety of linaclotide in patients with chronic constipation.